Ozone primes alveolar macrophage-derived innate immunity in healthy human subjects.
Department of Medicine, Duke University Medical Center, Durham, NC.
Benjamin W
BW
Frush
Department of Medicine, Duke University Medical Center, Durham, NC.
Zhuowei
Z
Li
Department of Medicine, Duke University Medical Center, Durham, NC.
Jane V
JV
Stiles
Department of Medicine, Duke University Medical Center, Durham, NC.
Sarah F
SF
Cotter
Department of Medicine, Duke University Medical Center, Durham, NC.
Scott L
SL
Shofer
Department of Medicine, Duke University Medical Center, Durham, NC.
W Michael
WM
Foster
Department of Medicine, Duke University Medical Center, Durham, NC.
John W
JW
Hollingsworth
Department of Medicine, Duke University Medical Center, Durham, NC. Electronic address: robert.tighe@duke.edu.
Robert M
RM
Tighe
D000280:Administration, Inhalation; D000328:Adult; D000818:Animals; D005260:Female; D064368:Healthy Volunteers; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D066298:In Vitro Techniques; D018950:Lipopolysaccharide Receptors / Q000235:genetics; D008070:Lipopolysaccharides / Q000494:pharmacology; D016676:Macrophages, Alveolar / Q000187:drug effects* / Q000276:immunology* / Q000378:metabolism; D008297:Male; D051379:Mice; D010126:Ozone / Q000008:administration & dosage / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D051197:Toll-Like Receptor 4 / Q000235:genetics; D055815:Young Adult
D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D012333:RNA, Messenger; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4; D010126:Ozone; D013755:Tetradecanoylphorbol Acetate